Acquisition of natural humoral immunity to P. falciparum in early life in Benin: Impact of clinical, environmental and host factors

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Dechavanne, Célia ^a,b   Sadissou, Ibrahim ^c   Bouraima, Aziz ^c   Ahouangninou, Claude ^c   Amoussa, Roukiyath ^c   Milet, Jacqueline ^a,b   Moutairou, Kabirou ^c   Massougbodji, Achille ^c   Theisen, Michael ^d,e   Remarque, Edmond J ^f   Courtin, David ^a,b   Nuel, Gregory ^g   Migot Nabias, Florence ^a,b   Garcia, André ^a,b  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF ABOMEY CALAVI   (Benin)

^d STATENS SERUM INSTITUT   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^g UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84989220951     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep33961     Document Type: Article

References (45)

1. Dobano, C. et al. Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children. Clin. Vaccine Immunol. CVI 19, 157-166 (2012).
2. Sarr, J. B. et al. Evaluation of antibody response to Plasmodium falciparum in children according to exposure of Anopheles gambiae s.l or Anopheles funestus vectors. Malar. J. 6, 117 (2007).
3. Baird, J. K. Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol. Today Pers. Ed 11, 105-111 (1995).
4. Reeder, J. C., Davern, K. M., Baird, J. K., Rogerson, S. J. & Brown, G. V. The age-specific prevalence of Plasmodium falciparum in migrants to Irian Jaya is not attributable to agglutinating antibody repertoire. Acta Trop. 65, 163-173 (1997).
5. Drakeley, C. J. et al. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc. Natl. Acad. Sci. USA. 102, 5108-5113 (2005).
6. Khaireh, B. A. et al. Plasmodium vivax and Plasmodium falciparum infections in the Republic of Djibouti: evaluation of their prevalence and potential determinants. Malar. J. 11, 395 (2012).
7. Genton, B., Al-Yaman, F., Ginny, M., Taraika, J. & Alpers, M. P. Relation of anthropometry to malaria morbidity and immunity in Papua New Guinean children. Am. J. Clin. Nutr. 68, 734-741 (1998).
8. Fillol, F. et al. Impact of child malnutrition on the specific anti-Plasmodium falciparum antibody response. Malar. J. 8, 116 (2009).
9. Aidoo, M. et al. Protective effects of the sickle cell gene against malaria morbidity and mortality. The Lancet 359, 1311-1312 (2002).
10. Williams, T. N. et al. An immune basis for malaria protection by the sickle cell trait. PLoS Med. 2, e128 (2005).
11. Malhotra, I. et al. Can prenatal malaria exposure produce an immune tolerant phenotype ? A prospective birth cohort study in Kenya. PLoS Med. 6, e1000116 (2009).
12. Le Port, A. et al. First malaria infections in a cohort of infants in Benin: biological, environmental and genetic determinants. Description of the study site, population methods and preliminary results. BMJ Open 2, e000342 (2012).
13. Bonner, P. C. et al. Placental malaria diminishes development of antibody responses to Plasmodium falciparum epitopes in infants residing in an area of western Kenya where P. falciparum is endemic. Clin. Diagn. Lab. Immunol. 12, 375-379 (2005).
14. Dent, A. et al. Prenatal malaria immune experience affects acquisition of Plasmodium falciparum merozoite surface protein-1 invasion inhibitory antibodies during infancy. J. Immunol. Baltim. Md 1950 177, 7139-7145 (2006).
15. Stanisic, D. I. et al. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Infect. Immun. 77, 1165-1174 (2009).
16. Dodoo, D. et al. Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children. Malar. J. 7, 142 (2008).
17. Courtin, D. et al. The quantity and quality of African childrens IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria. PloS One 4, e7590 (2009).
18. Cottrell, G. et al. Modeling the influence of local environmental factors on malaria transmission in Benin and its implications for cohort study. PloS One 7, e28812 (2012).
19. Le Port, A. et al. Importance of adequate local spatiotemporal transmission measures in malaria cohort studies: application to the relation between placental malaria and first malaria infection in infants. Am. J. Epidemiol. 178, 136-143 (2013).
20. Pombo, D. J. et al. Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet 360, 610-617 (2002).
21. Ndungu, F. M. et al. Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in nolonger exposed children. Proc. Natl. Acad. Sci. USA. 109, 8247-8252 (2012).
22. Dobbs, K. R. & Dent, A. Plasmodium malaria and antimalarial antibodies in the first year of life. Parasitology 143, 129-138 (2016).
23. Dechavanne, C., Cottrell, G., Garcia, A. & Migot-Nabias, F. Placental Malaria: Decreased Transfer of Maternal Antibodies Directed to Plasmodium falciparum and Impact on the Incidence of Febrile Infections in Infants. PloS One 10, e0145464 (2015).
24. Field, C. J., Johnson, I. R. & Schley, P. D. Nutrients and their role in host resistance to infection. J. Leukoc. Biol. 71, 16-32 (2002).
25. Shankar, A. H. & Prasad, A. S. Zinc and immune function: the biological basis of altered resistance to infection. Am. J. Clin. Nutr. 68, 447S-463S (1998).
26. Kangoye, D. T. et al. Plasmodium falciparum malaria in children aged 0-2 years: the role of foetal haemoglobin and maternal antibodies to two asexual malaria vaccine candidates (MSP3 and GLURP). PloS One 9, e107965 (2014).
27. Duah, N. O., Miles, D. J. C., Whittle, H. C. & Conway, D. J. Acquisition of antibody isotypes against Plasmodium falciparum blood stage antigens in a birth cohort. Parasite Immunol. 32, 125-134 (2010).
28. White, M. T. et al. Dynamics of the antibody response to Plasmodium falciparum infection in African children. J. Infect. Dis. 210, 1115-1122 (2014).
29. Metzger, W. G. et al. Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria. Parasite Immunol. 25, 307-312 (2003).
30. Gray, J. C. et al. Profiling the antibody immune response against blood stage malaria vaccine candidates. Clin. Chem. 53, 1244-1253 (2007).
31. Djnontin, A. et al. Culicidae diversity, malaria transmission and insecticide resistance alleles in malaria vectors in Ouidah- Kpomasse-Tori district from Benin (West Africa): A pre-intervention study. Parasit. Vectors 3, 83 (2010).
32. WHO. Indicators for assessing infant and young child feeding practices: part 2: measurement. (2010).
33. Faber, B. W. et al. Production, quality control, stability and pharmacotoxicity of cGMP-produced Plasmodium falciparum AMA1 FVO strain ectodomain expressed in Pichia pastoris. Vaccine 26, 6143-6150 (2008).
34. Bonnet, S. et al. Soluble and glyco-lipid modified baculovirus Plasmodium falciparum C-terminal merozoite surface protein 1, two forms of a leading malaria vaccine candidate. Vaccine 24, 5997-6008 (2006).
35. Anders, R. F., Adda, C. G., Foley, M. & Norton, R. S. Recombinant protein vaccines against the asexual blood stages of Plasmodium falciparum. Hum. Vaccin. 6, 39-53 (2010).
36. McCarthy, J. S. et al. A phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide® ISA 720. PloS One 6, e24413 (2011).
37. Carvalho, L. J. M. et al. Immunization of Saimiri sciureus monkeys with a recombinant hybrid protein derived from the Plasmodium falciparum antigen glutamate-rich protein and merozoite surface protein 3 can induce partial protection with Freund and Montanide ISA720 adjuvants. Clin. Diagn. Lab. Immunol. 12, 242-248 (2005).
38. Theisen, M., Vuust, J., Gottschau, A., Jepsen, S. & Hgh, B. Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli. Clin. Diagn. Lab. Immunol. 2, 30-34 (1995).
39. Nebie, I. et al. Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa. Infect. Immun. 76, 759-766 (2008).
40. Lusingu, J. P. A. et al. Cytophilic antibodies to Plasmodium falciparum glutamate rich protein are associated with malaria protection in an area of holoendemic transmission. Malar. J. 4, 48 (2005).
41. Celeux, G. & Diebolt, J. SEM algorithm: a probabilistic learning algorithm for recognition of density mixtures. Rev. Stat. Appliquee 34, 35-52 (1986).
42. Moulton, L. H. & Halsey, N. A. A mixture model with detection limits for regression analyses of antibody response to vaccine. Biometrics 51, 1570-1578 (1995).
43. Rasheed, F. N. et al. Relationships between maternal malaria and malarial immune responses in mothers and neonates. Parasite Immunol. 17, 1-10 (1995).
44. Migot-Nabias, F. et al. Red blood cell polymorphisms in relation to Plasmodium falciparum asymptomatic parasite densities and morbidity in Senegal. Microbes Infect. Inst. Pasteur 8, 2352-2358 (2006).
45. McCulloch, C. E., Searle, S. R. & Neuhaus, John M. Generalized, linear, and mixed models. (Wiley, 2008).